Hybrid Closed Loop Insulin Pump and Bariatric Surgery in Patients With Type 1 Diabetes
Bariatric surgery is increasingly performed on patients with type 1 diabetes. It exposes these patients to an increased risk of hypoglycemia, including severe hypoglycemia, and of severe episodes of hyperglycemia, beyond the perioperative period. The long-term efficacy and safety of hybrid closed-loop insulin pump in these patients has not yet been published.
- EligibilityCriteria: Inclusion Criteria:  Major patient With type 1 diabetes for > 1 year Obese (BMI≥30) Having undergone bariatric surgery On a hybrid closed-loop insulin pump Not pregnant No hybrid closed-loop insulin pump discontinuation for more than 45 days after surgery  Exclusion Criteria:  - Patient informed and opposed to data use - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Patient with type 1 diabetes who underwent bariatric surgery and treated by hybrid closed-loop insulin pump. - SamplingMethod: Non-Probability Sample